These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17294803

  • 1. Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy.
    Oktem G, Bilir A, Ayla S, Yavasoglu A, Goksel G, Saydam G, Uysal A.
    Oncol Res; 2006; 16(5):225-33. PubMed ID: 17294803
    [Abstract] [Full Text] [Related]

  • 2. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids.
    Oktem G, Vatansever S, Ayla S, Uysal A, Aktas S, Karabulut B, Bilir A.
    Oncol Rep; 2006 Feb; 15(2):335-40. PubMed ID: 16391851
    [Abstract] [Full Text] [Related]

  • 3. Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.
    Monazzam A, Josephsson R, Blomqvist C, Carlsson J, Långström B, Bergström M.
    Breast Cancer Res; 2007 Feb; 9(4):R45. PubMed ID: 17659092
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line.
    Oktem G, Bilir A, Selvi N, Yurtseven ME, Vatansever S, Ates U, Uysal A, Omay SB.
    Oncol Res; 2006 Feb; 16(4):195-203. PubMed ID: 17120617
    [Abstract] [Full Text] [Related]

  • 5. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J, Melguizo C, Rama AR, Ortiz R, Segura A, Boulaiz H, Vélez C, Caba O, Ramos JL, Aránega A.
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [Abstract] [Full Text] [Related]

  • 6. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR, Prados J, Melguizo C, Burgos M, Alvarez PJ, Rodriguez-Serrano F, Ramos JL, Aranega A.
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H, Taira N, Nogami T, Shien K, Okada M, Shien T, Doihara H, Miyoshi S.
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [Abstract] [Full Text] [Related]

  • 8. 3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro.
    Brancato V, Gioiella F, Imparato G, Guarnieri D, Urciuolo F, Netti PA.
    Acta Biomater; 2018 Jul 15; 75():200-212. PubMed ID: 29864516
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin and α-Mangostin oppositely affect luminal breast cancer cell stemness evaluated by a new retinaldehyde-dependent ALDH assay in MCF-7 tumor spheroids.
    Bissoli I, Muscari C.
    Biomed Pharmacother; 2020 Apr 15; 124():109927. PubMed ID: 31982725
    [Abstract] [Full Text] [Related]

  • 10. From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer.
    Rodallec A, Sicard G, Giacometti S, Carré M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R.
    Int J Nanomedicine; 2018 Apr 15; 13():6677-6688. PubMed ID: 30425482
    [Abstract] [Full Text] [Related]

  • 11. Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles.
    Holub AR, Huo A, Patel K, Thakore V, Chhibber P, Erogbogbo F.
    Int J Mol Sci; 2020 Jun 21; 21(12):. PubMed ID: 32575896
    [Abstract] [Full Text] [Related]

  • 12. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
    Godugu C, Patel AR, Desai U, Andey T, Sams A, Singh M.
    PLoS One; 2013 Jun 21; 8(1):e53708. PubMed ID: 23349734
    [Abstract] [Full Text] [Related]

  • 13. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
    Uematsu N, Zhao Y, Kiyomi A, Yuan BO, Onda K, Tanaka S, Sugiyama K, Sugiura M, Takagi N, Hayakawa A, Hirano T.
    Anticancer Res; 2018 Apr 21; 38(4):2101-2108. PubMed ID: 29599328
    [Abstract] [Full Text] [Related]

  • 14. 3'-Deoxy-3'-[(18)F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment.
    Dittmann H, Jusufoska A, Dohmen BM, Smyczek-Gargya B, Fersis N, Pritzkow M, Kehlbach R, Vonthein R, Machulla HJ, Bares R.
    Nucl Med Biol; 2009 Feb 21; 36(2):163-9. PubMed ID: 19217528
    [Abstract] [Full Text] [Related]

  • 15. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant.
    dit Faute MA, Laurent L, Ploton D, Poupon MF, Jardillier JC, Bobichon H.
    Clin Exp Metastasis; 2002 Feb 21; 19(2):161-8. PubMed ID: 11964080
    [Abstract] [Full Text] [Related]

  • 16. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.
    Zeng S, Chen YZ, Fu L, Johnson KR, Fan W.
    Clin Cancer Res; 2000 Sep 21; 6(9):3766-73. PubMed ID: 10999771
    [Abstract] [Full Text] [Related]

  • 17. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
    Lee SY, Jeong EK, Jeon HM, Kim CH, Kang HS.
    Oncol Rep; 2010 Jul 21; 24(1):73-9. PubMed ID: 20514446
    [Abstract] [Full Text] [Related]

  • 18. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
    Trebunova M, Laputkova G, Slaba E, Lacjakova K, Verebova A.
    Anticancer Res; 2012 Jul 21; 32(7):2849-54. PubMed ID: 22753747
    [Abstract] [Full Text] [Related]

  • 19. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
    Chitcholtan K, Sykes PH, Evans JJ.
    J Transl Med; 2012 Mar 06; 10():38. PubMed ID: 22394685
    [Abstract] [Full Text] [Related]

  • 20. Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells.
    Jeong EK, Lee SY, Jeon HM, Ju MK, Kim CH, Kang HS.
    Int J Oncol; 2010 Sep 06; 37(3):655-61. PubMed ID: 20664934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.